Literature DB >> 5467162

Spironolactone therapy and amenorrhea.

J I Levitt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5467162

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  Hirsutism and the effectiveness of spironolactone in its management.

Authors:  G R McMullen; A J Van Herle
Journal:  J Endocrinol Invest       Date:  1993-12       Impact factor: 4.256

Review 2.  Drug-induced sexual dysfunction.

Authors:  D E McWaine; W R Procci
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jul-Aug

3.  The interaction of canrenone with oestrogen and progesterone receptors in human uterine cytosol.

Authors:  M D Fernandez; G D Carter; T N Palmer
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

4.  Antiandrogenic properties of spironolactone. Clinical trial in the management of female hirsutism.

Authors:  M Messina; C Manieri; P Biffignandi; C Massucchetti; R F Novi; G M Molinatti
Journal:  J Endocrinol Invest       Date:  1983-02       Impact factor: 4.256

Review 5.  Interfering with mineralocorticoid receptor activation: the past, present, and future.

Authors:  Anne M Dorrance
Journal:  F1000Prime Rep       Date:  2014-08-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.